Velphoro
Brand Name: Velphoro
Generic Name: Sucroferric oxyhydroxide
Active
Registration Number
DR-XY47564
Dosage Form
Chewable Tablet
Issuance Date
March 25, 2025
Expiry Date
March 25, 2030
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength2.5 g
Packaging150 mL-Capacity HDPE Bottle containing 30 Tablets. with Child-Resistant PP Closure (Box of 30 Tablets); 30 Tablets); 400 mL-Capacity HPDE Bottle containing 90 Tablets with Child-Resistant PP Closure (Box of 90 Tablets)
Classification
C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Drug for treatment of Hyperkalemia and Hyperphosphatemia
A
Application
Initial (from Monitored Release status)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Sucroferric oxyhydroxideActive
Monograph: Iron sucrose